Applied UV, Inc. · OTC:AUVI

Applied UV — Investor Presentation (April 2023)

25 slides from Applied UV's investor presentation, Apr 21, 2023

  1. Slide 1: Investor Presentation

    March 2023 Nasdaq: AUVI, AUVIP B e # e r A i r. B e # e r L i g h t . B e # e r B u s i n e s s . B e # e r L i f e . ™ Investor Presentation Global Leader in Integrated Innovations for Air and Surface Pathogen Elimination and Disinfection, LED Lighting and Hospitality Furnishings April 2023 Our Bra

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement Nasdaq: AUVI, AUVIP This presentation may contain “forward-looking statements.” Forward-looking statements reflect the current view about future events. When used in this prospectus, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” or the neg

  3. Slide 3: Investor Highlights

    Investor Highlights Nasdaq: AUVI, AUVIP AUVI is a fully integrated sales and marketing company offering proprietary, patented air and surface (fixed, consumer, HVAC and mobile) pathogen elimination and disinfection products, LED lighting and luxury mirrors and premium hospitality furnishings to glob

  4. Slide 4: Investor Key Highlights Takeaways

    Investor Key Highlights Takeaways Nasdaq: AUVI, AUVIP MARKET: UV Disinfection market is expected to reach $9 billion by 2026 - CDC estimates that 01 GROWING MARKET 1 in 25 patients have at least one HAI annually & 3M serious infections occur every year with total losses to U.S. economy of more than

  5. Slide 5: UV Disinfection Market: Compelling Growth Drivers

    UV Disinfection Market: Compelling Growth Drivers Nasdaq: AUVI, AUVIP Global air purifier market size is set to grow exponentially. It was valued at USD 9.24 billion in 2021 and is predicted to reach USD 22.84 billion by 2030; UV Disinfection market is expected to reach USD 9 billion by 2026 as tech

  6. Slide 6: Deeper Dive - Product Overview

    Deeper Dive - Product Overview Nasdaq: AUVI, AUVIP Applied UV offers lab validated, data driven disinfection solutions for air and surface applications Air Purification Surface Disinfection Independently tested for and eliminates COVID-19 Independently tested for and eliminates OC-43, a surrogate fo

  7. Slide 7: Air Disinfection

    Air Disinfection Nasdaq: AUVI, AUVIP o Developed for NASA to provide safe, clean air o Destroys 99.99% of airborne bacteria, mold, fungi and viruses o Advanced bioconversion technology uses photocatalytic oxidation to fully destroy airborne bacteria, mold, fungi, viruses, volatile organic compounds,

  8. Slide 8: Facility Level Disinfection Solutions

    HVAC Air Disinfection Nasdaq: AUVI, AUVIP Facility Level Disinfec0on Solu0ons o Innovative HVAC air and coil disinfection solutions o Continuous in-room air disinfection technologies o Hospital-grade surface disinfection solutions o Patented air and surface technologies © Copyright 2022 Applied UV,

  9. Slide 9: PURONet UV IAQ Disinfection Control System

    IAQ Monitoring Software Nasdaq: AUVI, AUVIP PURONet UV IAQ Disinfection Control System UV Safety, Control and Reporting All In One Place o First control system of its kind specifically designed for user-friendly operation o Controls PURO Fixtures within a room providing safe operation and data colle

  10. Slide 10: Mobile Air Disinfection

    Mobile Air Disinfection Nasdaq: AUVI, AUVIP o Laboratory validated 99.99%+ kill rate on viruses, bacteria, mold, odors and VOCS o NO harmful by-products o Rapid, portable, whole-room disinfeckon via patented 3-phase design (HEPA, UV-C, Carbon) o Proven and tested in facilikes with EPA and FDA guidel

  11. Slide 11: Surface Disinfection

    Surface Disinfection Nasdaq: AUVI, AUVIP Backed by Biosafety Level II and III labs, is proven to kill 99.99%+ of pathogens on surfaces including: • SARS-CoV-2 surrogate (OC-43), MRSA, H1N1, Candida Auris (C. auris), C. diff and E. coli • June 2022 Mt Sinai Medical Center Morningside Installed with A

  12. Slide 12: Strong Business Case Use Across Multiple Verticals

    Strong Business Case Use Across Multiple Verticals IAQ Product Suite From Small Applica<ons to Commercial / Heavy Industrial Agriculture Transportation Healthcare Food and Beverage Post-harvest Food Distribution and Logistics Hospitals Winery, Dairy, Meat & Preservations and Cannabis from “Farm To T

  13. Slide 13: Competitive Advantages

    Competitive Advantages Nasdaq: AUVI, AUVIP AUVI is one of the only research-backed, clinically-proven air and surface disinfection technology companies with international distribution and globally recognized end users with product developed for NASA Few Dominant Players Global Push Highly fragmented

  14. Slide 14: Differentiator - Global Distribution Footprint

    DifferenHator - Global DistribuHon Footprint Nasdaq: AUVI, AUVIP Scandinavia Europe • One Major Distributor (Dental) • One Master Distributor • 20 Retailers Asia • Nine Dealer Distributors United States • 24 Dealers/Distributors • 5-10 New Direct Sales Vietnam • Nine Dealer Distributors South America

  15. Slide 15: Backed By Compelling Research

    Backed By Compelling Research Nasdaq: AUVI, AUVIP MRIGlobal, an independent, not-profit, Kansas City, Missouri GSU Study – Pulsed broad-spectrum UV Light actively inactivates SARS-CoV-2 – § Demonstrated effec[ve removal of aerosolized SARS- https://www.biorxiv.org/content/10.1101/2021.02.12.431032v1

  16. Slide 16: Hospitality Segment

    A global manufacturer of luxury and backlit mirrors, patented - disinfeckon mirrors uklizing the SteriLumen proprietary PCO technology and premium conference room and living space furnishings, specifically for the hospitality industry Hospitality Segment Nasdaq: AUVI, AUVIP © Copyright 2021 Applied U

  17. Slide 17: LED Lighting Segment

    LED Lighting Segment Nasdaq: AUVI, AUVIP Single Source Lighting, Controls and Technology Provider By offering more products and technologies, we help streamline decisions, save time and resources at the corporate level down through construction for new construction and renovation projects: o LED Lig

  18. Slide 18: Organic Growth - Marketing

    Organic Growth - Marketing Nasdaq: AUVI, AUVIP Effective and efficient marketing that increases customer count and revenue and wins the hearts and minds of target audience Targeted Product by Integrated Marketing Performance Metrics Ver\cal Programs • Increase quality sales leads Airocide • Digital

  19. Slide 19: Consolidated Statement of Operations

    Consolidated Statement of Operations Nasdaq: AUVI, AUVIP 2022 2021 Net Sales $ 20,139,849 $ 11,667,579 Cost of Goods Sold 16,101,555 7,569,193 Gross Profit 4,038,294 4,098,386 Net Sales by Segment Operating Expenses Research and development 319,167 53,408 (Year end 12/31/2022) Selling general and ad

  20. Slide 20: Cap Table

    Cap Table Nasdaq: AUVI, AUVIP Preferred Stock Par Authorized / Issued and Outstanding Designated (as of March 31, 2023) Total Authorized $0.0001 20,000,000 Series A Cumulative Perpetual $0.0001 1,250,000 552,000 Series B Cumulative Perpetual $0.0001 1,250,000 1,250,000 Series C Cumulative Perpetual

  21. Slide 21: Experienced Leadership Team

    Experienced Leadership Team Nasdaq: AUVI, AUVIP Max Munn Michael Riccio Brian Stern Andrew Lawrence Founder, CEO, President CFO President PURO UV President LED Supply CO and Director and Director • Mr. Munn has held this position at • Former CFO and Treasurer of • Co-Founder of both PURO • Co-Founde

  22. Slide 22: Experienced, Independent Board

    Experienced, Independent Board Nasdaq: AUVI, AUVIP • President/CEO GranCare Inc, acquired by Apollo and merged with Living Centers of America to form Mariner • Chairman Mariner Post-Acute Network • President/COO and Director American Medical International (AMI) • Chairman Alterra Healthcare • Invest

  23. Slide 23: Scientific Advisory Board

    Scientific Advisory Board Nasdaq: AUVI, AUVIP • Professor of Medicine at the Icahn School of Medicine at Mount Sinai and the Infection Prevention Medical Director for the eight-hospital Mount Sinai Health System in NY • Dr. Cumins received his medical degree from Emory University School of Medicine

  24. Slide 24: Looking Ahead: 2023 and Beyond

    Target Key Verticals Prioritize Organic Growth Scalability Moving from opportunistic to Leverage cross selling opportunities• Fully optimize Canon focused approach with proven key among brands driven by: Virginia contract Looking Ahead: verticals • Govt mandates for healthcare manufacturing initiati

  25. Slide 25: Applied UV, Inc.

    Contact: Nasdaq: AUVI, AUVIP Applied UV, Inc. Max Munn Founder, CEO, President and Director 150 N. Macquesten Parkway Mount Vernon, NY 10550 914-391-6464 BeBer Air. BeBer Light. BeBer Business. BeBer Life.™

Applied UV — Investor Presentation (April 2023) on 6ix